PEMBROLIZUMAB Pharmacologic Class Indexing
- Class set ID
- 1d9ca4f3-8bd2-4749-8811-020b0ec633d7
- Version
- 3
- Effective date
- 20251030
- Type
- Indexing - Pharmacologic Class
Mapped DailyMed Labels#
| Label | Manufacturer | Effective | SPL version |
|---|---|---|---|
| These highlights do not include all the information needed to use KEYTRUDA QLEX safely and effectively. See full prescribing information for KEYTRUDA QLEX. KEYTRUDA QLEX ™ (pembrolizumab and berahyaluronidase alfa-pmph) injection, for subcutaneous use Initial U.S. Approval: 2025 | Merck Sharp & Dohme LLC | 20260512 | 14 |
| These highlights do not include all the information needed to use KEYTRUDA safely and effectively. See full prescribing information for KEYTRUDA. KEYTRUDA ® (pembrolizumab) injection, for intravenous use Initial U.S. Approval: 2014 | Merck Sharp & Dohme LLC | MSD International Business GmbH | 20260512 | 225 |